Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3021 | 2041 | 36.2 | 80% |
Classes in level above (level 3) |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
7591 | 1270 | GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO |
13469 | 771 | THROMBOCYTOSIS//TCIPA//TUMOR CELL INDUCED PLATELET AGGREGATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GLASGOW PROGNOSTIC SCORE | Author keyword | 151 | 90% | 3% | 65 |
2 | NEUTROPHIL TO LYMPHOCYTE RATIO | Author keyword | 53 | 45% | 4% | 89 |
3 | NEUTROPHIL LYMPHOCYTE RATIO | Author keyword | 44 | 43% | 4% | 78 |
4 | INFLAMMATION BASED PROGNOSTIC SCORE | Author keyword | 27 | 92% | 1% | 11 |
5 | PLATELET LYMPHOCYTE RATIO | Author keyword | 21 | 57% | 1% | 25 |
6 | PLATELET TO LYMPHOCYTE RATIO | Author keyword | 18 | 58% | 1% | 21 |
7 | THROMBOCYTOSIS | Author keyword | 18 | 19% | 4% | 86 |
8 | PROGNOSTIC NUTRITIONAL INDEX | Author keyword | 17 | 72% | 1% | 13 |
9 | MGPS | Author keyword | 15 | 77% | 0% | 10 |
10 | TCIPA | Author keyword | 12 | 86% | 0% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLASGOW PROGNOSTIC SCORE | 151 | 90% | 3% | 65 | Search GLASGOW+PROGNOSTIC+SCORE | Search GLASGOW+PROGNOSTIC+SCORE |
2 | NEUTROPHIL TO LYMPHOCYTE RATIO | 53 | 45% | 4% | 89 | Search NEUTROPHIL+TO+LYMPHOCYTE+RATIO | Search NEUTROPHIL+TO+LYMPHOCYTE+RATIO |
3 | NEUTROPHIL LYMPHOCYTE RATIO | 44 | 43% | 4% | 78 | Search NEUTROPHIL+LYMPHOCYTE+RATIO | Search NEUTROPHIL+LYMPHOCYTE+RATIO |
4 | INFLAMMATION BASED PROGNOSTIC SCORE | 27 | 92% | 1% | 11 | Search INFLAMMATION+BASED+PROGNOSTIC+SCORE | Search INFLAMMATION+BASED+PROGNOSTIC+SCORE |
5 | PLATELET LYMPHOCYTE RATIO | 21 | 57% | 1% | 25 | Search PLATELET+LYMPHOCYTE+RATIO | Search PLATELET+LYMPHOCYTE+RATIO |
6 | PLATELET TO LYMPHOCYTE RATIO | 18 | 58% | 1% | 21 | Search PLATELET+TO+LYMPHOCYTE+RATIO | Search PLATELET+TO+LYMPHOCYTE+RATIO |
7 | THROMBOCYTOSIS | 18 | 19% | 4% | 86 | Search THROMBOCYTOSIS | Search THROMBOCYTOSIS |
8 | PROGNOSTIC NUTRITIONAL INDEX | 17 | 72% | 1% | 13 | Search PROGNOSTIC+NUTRITIONAL+INDEX | Search PROGNOSTIC+NUTRITIONAL+INDEX |
9 | MGPS | 15 | 77% | 0% | 10 | Search MGPS | Search MGPS |
10 | TCIPA | 12 | 86% | 0% | 6 | Search TCIPA | Search TCIPA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PREOPERATIVE NEUTROPHIL | 79 | 72% | 3% | 63 |
2 | NEUTROPHIL LYMPHOCYTE RATIO | 65 | 48% | 5% | 99 |
3 | NEUTROPHIL LYMPHOCYTE | 61 | 95% | 1% | 20 |
4 | PRETREATMENT NEUTROPHIL | 59 | 81% | 2% | 35 |
5 | PREOPERATIVE ELEVATION | 44 | 73% | 2% | 33 |
6 | ELEVATED PREOPERATIVE NEUTROPHIL | 35 | 86% | 1% | 18 |
7 | LYMPHOCYTE RATIO | 32 | 31% | 4% | 86 |
8 | THROMBOCYTOSIS | 26 | 25% | 5% | 92 |
9 | SYSTEMIC INFLAMMATORY RESPONSE | 25 | 13% | 9% | 175 |
10 | PRETREATMENT THROMBOCYTOSIS | 23 | 100% | 0% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer | 2013 | 73 | 63 | 90% |
The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer | 2013 | 81 | 73 | 82% |
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis | 2014 | 26 | 104 | 78% |
Prognostic role of neutrophil- to- lymphocyte ratio in colorectal cancer: A systematic review and meta- analysis | 2014 | 29 | 37 | 57% |
A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours | 2014 | 15 | 58 | 79% |
Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis | 2014 | 15 | 44 | 68% |
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer | 2010 | 188 | 119 | 76% |
Prognostic significance of the neutrophil to lymphocyte ratio in patients with non-small cell lung cancer: a systemic review and meta-analysis | 2015 | 1 | 24 | 63% |
Platelets in Tumor Progression: A Host Factor That Offers Multiple Potential Targets in the Treatment of Cancer | 2014 | 14 | 96 | 48% |
Immunomonitoring and prognostic relevance of neutrophils in clinical trials | 2013 | 35 | 61 | 56% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNIT GENET EPIDEMIOL PHARMACOGENET | 7 | 53% | 0.5% | 10 |
2 | WEST SCOTLAND COLORECTAL CANC MANAGED CLIN NETWOR | 4 | 75% | 0.1% | 3 |
3 | GEORGE W COMSTOCK PUBL HLTH PREVENT | 2 | 36% | 0.2% | 5 |
4 | BIOMED PHYSIOPATHOL OBES NUTR CIBER CB0 | 2 | 67% | 0.1% | 2 |
5 | HISTOL EMBRIOL GENET | 2 | 67% | 0.1% | 2 |
6 | PL SHUPIK KYIV MED POST EDUC | 2 | 67% | 0.1% | 2 |
7 | OPERATING THEATRE | 2 | 29% | 0.3% | 6 |
8 | WEST SCOTLAND CANC SURVEILLANCE UNIT | 2 | 29% | 0.3% | 6 |
9 | CLIN RADIOTHER EUT ONCOL | 1 | 100% | 0.1% | 2 |
10 | HLTH BEHAV SCI HLTH EDUC | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000020109 | CANCER CACHEXIA//CACHEXIA//PROTEOLYSIS INDUCING FACTOR |
2 | 0.0000015722 | INFLAMMASOME//C REACTIVE PROTEIN//NLRP3 |
3 | 0.0000013335 | THROMBOPOIETIN//ONCOSTATIN M//LEUKEMIA INHIBITORY FACTOR |
4 | 0.0000010552 | PULMONARY EMBOLISM//VENOUS THROMBOEMBOLISM//DEEP VEIN THROMBOSIS |
5 | 0.0000010223 | LAMININ//FIBRONECTIN//INVASION & METASTASIS |
6 | 0.0000009919 | P15E//IMMUNE SUPPRESSOR CELLS//IRX 2 |
7 | 0.0000009626 | ALPHAVBETA3 INTEGRIN//CILENGITIDE//DISCOIDIN DOMAIN RECEPTOR |
8 | 0.0000009499 | CHEMOKINE//CXCR4//CHEMOKINES |
9 | 0.0000008862 | CYCLOOXYGENASE 2//COX 2//CYCLOOXYGENASE |
10 | 0.0000008574 | CA 125//CYFRA 21 1//HE4 |